ADAM15 Disintegrin is Associated with Aggressive Prostate and Breast Cancer Disease

Overview

Journal Neoplasia

Publisher Elsevier

Specialty Oncology

Date 2006 Jun 8

PMID 16756724

Citations 45

Authors

Rainer Kuefer

Kathleen C Day

Celina G Kleer

Michael S Sabel

Matthias D Hofer

Sooryanarayana Varambally

Christoph S Zorn

Arul M Chinnaiyan

Mark A Rubin

Mark L Day

Affiliations

Soon will be listed here.

Abstract

The aim of the current study was to evaluate the expression of ADAM15 disintegrin (ADAM15) in a broad spectrum of human tumors. The transcript for ADAM15 was found to be highly upregulated in a variety of tumor cDNA expression arrays. ADAM15 protein expression was examined in tissue microarrays (TMAs) consisting of 638 tissue cores. TMA analysis revealed that ADAM15 protein was significantly increased in multiple types of adenocarcinoma, specifically in prostate and breast cancer specimens. Statistical association was observed with disease progression within clinical parameters of predictive outcome for both prostate and breast cancers, pertaining to Gleason sum and angioinvasion, respectively. In this report, we also present data from a cDNA microarray of prostate cancer (PCa), where we compared transfected LNCaP cells that overexpress ADAM15 to vector control cells. In these experiments, we found that ADAM15 expression was associated with the induction of specific proteases and protease inhibitors, particularly tissue inhibitor of metalloproteinase 2, as validated in a separate PCa TMA. These results suggest that ADAM15 is generally overexpressed in adenocarcinoma and is highly associated with metastatic progression of prostate and breast cancers.

Citing Articles

A disintegrin and metallopeptidase domain (ADAM) 12, ADAM 17 mRNA and ADAM10 protein hold potential as biomarkers for detection of early gastric cancer.

Oh S, Lee S, Jin H, Choi S, Cha C, Lee J Sci Rep. 2025; 15(1):763.

PMID: 39755747 PMC: 11700123. DOI: 10.1038/s41598-024-84237-y.

The Potential of Extracellular Matrix- and Integrin Adhesion Complex-Related Molecules for Prostate Cancer Biomarker Discovery.

Samarzija I Biomedicines. 2024; 12(1).

PMID: 38255186 PMC: 10813710. DOI: 10.3390/biomedicines12010079.

Identification and Characterization of an HtrA Sheddase Produced by .

Omar Osman I, Caputo A, Pinault L, Mege J, Levasseur A, Devaux C Int J Mol Sci. 2023; 24(13).

PMID: 37446087 PMC: 10342153. DOI: 10.3390/ijms241310904.

A transcriptome-wide association study identifies novel candidate susceptibility genes for prostate cancer risk.

Liu D, Zhu J, Zhou D, Nikas E, Mitanis N, Sun Y Int J Cancer. 2021; 150(1):80-90.

PMID: 34520569 PMC: 8595764. DOI: 10.1002/ijc.33808.

Extracellular Matrix Biomarkers in Colorectal Cancer.

Kim M, Ha S, Wu M, Zogg H, Ronkon C, Lee M Int J Mol Sci. 2021; 22(17).

PMID: 34502094 PMC: 8430714. DOI: 10.3390/ijms22179185.

References

Rios-Doria J, Day K, Kuefer R, Rashid M, Chinnaiyan A, Rubin M . The role of calpain in the proteolytic cleavage of E-cadherin in prostate and mammary epithelial cells. J Biol Chem. 2002; 278(2):1372-9. DOI: 10.1074/jbc.M208772200. View

Seals D, Courtneidge S . The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes Dev. 2003; 17(1):7-30. DOI: 10.1101/gad.1039703. View

Glinsky G, Krones-Herzig A, Glinskii A . Malignancy-associated regions of transcriptional activation: gene expression profiling identifies common chromosomal regions of a recurrent transcriptional activation in human prostate, breast, ovarian, and colon cancers. Neoplasia. 2003; 5(3):218-28. PMC: 1502409. DOI: 10.1016/S1476-5586(03)80054-4. View

Horiuchi K, Weskamp G, Lum L, Hammes H, Cai H, Brodie T . Potential role for ADAM15 in pathological neovascularization in mice. Mol Cell Biol. 2003; 23(16):5614-24. PMC: 166329. DOI: 10.1128/MCB.23.16.5614-5624.2003. View

Fourie A, Coles F, Moreno V, Karlsson L . Catalytic activity of ADAM8, ADAM15, and MDC-L (ADAM28) on synthetic peptide substrates and in ectodomain cleavage of CD23. J Biol Chem. 2003; 278(33):30469-77. DOI: 10.1074/jbc.M213157200. View

White J . ADAMs: modulators of cell-cell and cell-matrix interactions. Curr Opin Cell Biol. 2003; 15(5):598-606. DOI: 10.1016/j.ceb.2003.08.001. View

Bogenrieder T, Herlyn M . Axis of evil: molecular mechanisms of cancer metastasis. Oncogene. 2003; 22(42):6524-36. DOI: 10.1038/sj.onc.1206757. View

Fischer O, Hart S, Gschwind A, Ullrich A . EGFR signal transactivation in cancer cells. Biochem Soc Trans. 2003; 31(Pt 6):1203-8. DOI: 10.1042/bst0311203. View

Schafer B, Gschwind A, Ullrich A . Multiple G-protein-coupled receptor signals converge on the epidermal growth factor receptor to promote migration and invasion. Oncogene. 2003; 23(4):991-9. DOI: 10.1038/sj.onc.1207278. View

10.

Nilsson M, Meza-Zepeda L, Mertens F, Forus A, Myklebost O, Mandahl N . Amplification of chromosome 1 sequences in lipomatous tumors and other sarcomas. Int J Cancer. 2004; 109(3):363-9. DOI: 10.1002/ijc.11716. View

11.

Watermann D, Madjar H, Sauerbrei W, Hirt V, Prompeler H, Stickeler E . Assessment of breast cancer vascularisation by Doppler ultrasound as a prognostic factor of survival. Oncol Rep. 2004; 11(4):905-10. View

12.

Polette M, Nawrocki-Raby B, Gilles C, Clavel C, Birembaut P . Tumour invasion and matrix metalloproteinases. Crit Rev Oncol Hematol. 2004; 49(3):179-86. DOI: 10.1016/j.critrevonc.2003.10.008. View

13.

Rhodes D, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D . ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia. 2004; 6(1):1-6. PMC: 1635162. DOI: 10.1016/s1476-5586(04)80047-2. View

14.

Noel A, Maillard C, Rocks N, Jost M, Chabottaux V, Sounni N . Membrane associated proteases and their inhibitors in tumour angiogenesis. J Clin Pathol. 2004; 57(6):577-84. PMC: 1770325. DOI: 10.1136/jcp.2003.014472. View

15.

Rios-Doria J, Kuefer R, Ethier S, Day M . Cleavage of beta-catenin by calpain in prostate and mammary tumor cells. Cancer Res. 2004; 64(20):7237-40. DOI: 10.1158/0008-5472.CAN-04-1048. View

16.

GLEASON D . Classification of prostatic carcinomas. Cancer Chemother Rep. 1966; 50(3):125-8. View

17.

Martin S, Mendelsohn G . Angioinvasion in breast carcinoma. An immunohistochemical study of factor VIII-related antigen. Cancer. 1987; 59(11):1918-22. DOI: 10.1002/1097-0142(19870601)59:11<1918::aid-cncr2820591113>3.0.co;2-y. View

18.

Wheelock M, Buck C, Bechtol K, Damsky C . Soluble 80-kd fragment of cell-CAM 120/80 disrupts cell-cell adhesion. J Cell Biochem. 1987; 34(3):187-202. DOI: 10.1002/jcb.240340305. View

19.

Fassler R, Meyer M . Consequences of lack of beta 1 integrin gene expression in mice. Genes Dev. 1995; 9(15):1896-908. DOI: 10.1101/gad.9.15.1896. View

20.

Wolfsberg T, Primakoff P, Myles D, White J . ADAM, a novel family of membrane proteins containing A Disintegrin And Metalloprotease domain: multipotential functions in cell-cell and cell-matrix interactions. J Cell Biol. 1995; 131(2):275-8. PMC: 2199973. DOI: 10.1083/jcb.131.2.275. View